Evidence map›Paper›PMID 24257035›Full record

ArticleToxins2013

Impact of antidepressants on cytokine production of depressed patients in vitro.

Alexander Munzer, Ulrich Sack, Roland Mergl, Jeremias Schönherr, Charlotte Petersein, Stefanie Bartsch, Kenneth C Kirkby, Katrin Bauer, Hubertus Himmerich

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Toxins, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04748523 (Effect of Mirtazapine Versus Placebo on Appetite, Nutritional Status and Quality of Life in Non-small Cell Lung cáncer Patients With Anorexia; Randomized Double-blind Clinical Trial.), which is not on this map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04748523 nacompletednot on this mapstarted 2018, after this paper: background citation

Effect of Mirtazapine Versus Placebo on Appetite, Nutritional Status and Quality of Life in Non-small Cell Lung cáncer Patients With Anorexia; Randomized Double-blind Clinical Trial.

TypeinterventionalSponsorInstituto Nacional de Cancerologia de MexicoRan2018 to 2022Enrolled86ConditionsAnorexia, Non-small Cell Lung CancerArmsMirtazapine, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Transdiagnostic Associations between Anger Hostility and Chemokine Interferon-gamma Inducible Protein 10.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  11. Article
  12. Article
  13. Dopamine, Immunity, and Disease.Pharmacological reviews · 2023
    Review
  14. Article
  15. Review
  16. Toxins · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alexander MunzerDepartment of Psychiatry, University of Leipzig, Semmelweisstr. 10, 04103 Leipzig, Germany. hubertus.himmerich@medizin.uni-leipzig.de.
Ulrich Sack
Roland Mergl
Jeremias Schönherr
Charlotte Petersein
Stefanie Bartsch
Kenneth C Kirkby
Katrin Bauer
Hubertus Himmerich
Leipzig University · DEUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interplay between immune and nervous systems plays a pivotal role in the pathophysiology of depression. In depressive episodes, patients show increased production of pro-inflammatory cytokines such as interleukin (IL)-1β and tumor necrosis factor (TNF)-α. There is limited information on the effect of antidepressant drugs on cytokines, most studies report on a limited sample of cytokines and none have reported effects on IL-22. We systematically investigated the effect of three antidepressant drugs, citalopram, escitalopram and mirtazapine, on secretion of cytokines IL-1β, IL-2, IL-4, IL-6, IL-17, IL-22 and TNF-α in a whole blood assay in vitro, using murine anti-human CD3 monoclonal antibody OKT3, and 5C3 monoclonal antibody against CD40, to stimulate T and B cells respectively. Citalopram increased production of IL-1β, IL-6, TNF-α and IL-22. Mirtazapine increased IL-1β, TNF-α and IL-22. Escitalopram decreased IL-17 levels. The influence of antidepressants on IL-2 and IL-4 levels was not significant for all three drugs. Compared to escitalopram, citalopram led to higher levels of IL-1β, IL-6, IL-17 and IL-22; and mirtazapine to higher levels of IL-1β, IL-17, IL-22 and TNF-α. Mirtazapine and citalopram increased IL-22 production. The differing profile of cytokine production may relate to differences in therapeutic effects, risk of relapse and side effects.

Indexed as

AdultAntidepressive AgentsCD40 AntigensCitalopramCytokinesDepressionFemaleHumansInterleukin-17Interleukin-1betaInterleukin-2Interleukin-22Interleukin-4Interleukin-6InterleukinsMaleAntidepressive AgentsCD40 AntigensCitalopramCytokinesInterleukin-17Interleukin-1betaInterleukin-2Interleukin-22Interleukin-4Interleukin-6InterleukinsMianserinMirtazapineMuromonab-CD3Tumor Necrosis Factor-alpha

Identifiers

PMID24257035
PMCPMC3847723
OpenAlexW2120334173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.